Background and aim: Hepatocellular carcinoma (HCC) is one of the most important health problem, with an increasing incidence worldwide. The aim of the present study was to determine the factors that predict HCC occurrence in a group of patients with liver cirrhosis developed on various etiologies.
Material and Methods: A total of 282 consecutive patients with liver cirrhosis seen between January 1, 2013 and July 31, 2014 were enrolled in a prospective study. Data from patient’s history, physical exams, laboratory tests and abdominal ultrasound were collected.
Results: 282 patients were included in the study with a median age of 59.6 and a male/female ratio of 1.38/1; 12.41% (35) were diagnosed with HCC. Alcohol consumption was documented in 19 cases (54.28%), without statistical association (p=0.621), and 7 (20%) were smokers (p=0.403). According to etiological factors of liver cirrhosis: 7 (20%) had background B virus infection, 15 (42.85%) HCV infection and 11 (31.42%) cases incriminated other causes of cirrhosis (alcohol). Chi2 test identified a statistically significant association between the occurrence of HCC and viral etiology of cirrhosis (p = 0.001, r = 18,830). No statistical association was found between Child Pugh scoring of cirrhosis and HCC (p=0.774) and a statistically significant association but inversely proportional was identified between neoplasia and obesity (p=0.008, r= -0.157).
Conclusion: In conclusion the viral etiology of liver cirrhosis is found to be an important risk factor for HCC, and liver cancer was inversely associated with nutritional status.
1. Brian I. Carr-Tumors of the liver and biliary tree, In: Dan L. Longo MD, Anthony S. Fauci MD, Harrison’s Gastroenterology and Hepatology, McGrawHill Education, United States, 2013:535-544.
2. EASL-EORTC- Clinical Practice Guidelines, Journal of Hepatology 2012;56:908-943.
3. National Cancer Institute. PDQ_ levels of evidence for adult and pediatric cancer treatment studies. Bethesda, MD: National Cancer Institute. Date last modified 26/August/2010. ;
4. Grieco A, Pompili, M, Caminiti, G, et al. Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre., Gut, 2005; 54,3:411-418.
5. Bosetti C, Levi F, Boffetta P, et al. Trends in mortality from hepatocellular carcinoma in Europe, 1980-2004. Hepatology 2008;48:137-145.
6. Yang HI, Sherman M, Su J, et al. Nomograms for Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Virus Infection. J Clin Oncol. 2010;28: 2437-2444.
7. Chen JD, Yang HI, Iloeje UH, et al. Carriers of Inactive Hepatitis B Virus Are Still at Risk forHepatocellular Carcinoma and Liver-Related Death. Gastroenterology 2010;135:1747-1754.
8. Dhir RN, Dworakowski W, Thangavel C, Shapiro BH. Sexually dimorphic regulation of hepatic isoforms of human cytochrome p450 by growth hormone. J Pharmacol Exp Ther 2006;316:87-94.
9. Waxman DJ, Holloway MG. Centennial perspective: sex differences in the expression of hepatic drug metabolizing enzymes. Mol Pharmacol 2009;76: 215-228.
10. Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004;127:5(1):S5-S16.
11. Kuper H, Tzonou A, Kaklamani E, et al. Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma. Int. J. Cancer 2000;85: 498-502.
12. Amarapurkar D, Das HS. Chronic liver disease in diabetes mellitus. Tropical Gastroenterol 2002;23:3-5.
13. El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004;126:460-468.
14. Ruhl CE, Everhart JE. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology 2003; 124:71-79.
15. Zen Y, Katayanagi K, Tsuneyama K, et al. Hepatocellular carcinoma arising in non-alcoholic steatohepatitis. Pathol Int 2001;51:127-131.
16. Sun B, Karin M. Obesity, inflammation, and liver cancer. J Hepatol 2012;56:704-713
17. Lok AS, Seeff LB, Morgan TR, et al. Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. Gastroenterology 2009;136:138-148.
18. Yang HI, Sherman M, Su J, et al. Nomograms for Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Virus Infection. J Clin Oncol 2010;28: 2437-2444.
19. Chen JD, Yang HI, Iloeje UH, et al. Carriers of Inactive Hepatitis B Virus Are Still at Risk forHepatocellular Carcinoma and Liver-Related Death. Gastroenterology 2010;135:1747-1754.